Considering thymalfasin therapy
Warning signs
The short answer: check claims about the medicine against its records. Pause if you cannot check who the doctor or other licensed health professional is, which pharmacy supplies it, or the explanation given.
As of September 28, 2026, a claim that thymosin alpha-1 is FDA-approved is false. The Food and Drug Administration (FDA) has given no approval to any product containing it.
Database claims
A National Drug Code (NDC) number does not prove that a product has approval; this is the FDA’s position as of September 26, 2026. NDC identifies an entry in a government directory for drugs.
As of September 28, 2026, the thymosin alpha-1 entries checked in that directory are powders used as raw ingredients to make medicines. They are not finished medicines ready to give to a patient.
Read the FDA directory explanationIn letters issued in 2026, the FDA described products labelled “research use only” and “not for human consumption.” It said the sellers’ websites still showed that they were offering the products for people to use as drugs. Those label words did not cancel the FDA’s concerns. The letters were accusations against named firms, not court decisions.
The FDA’s checklist calls for an online pharmacy to require a valid prescription, hold a state licence and give access to a licensed pharmacist. That checklist was checked for this guide on September 17, 2026. The US agency for consumer protection, the Federal Trade Commission, warns that a polished page or seal can be faked.
As of September 26, 2026, the US agency for consumer protection, the Federal Trade Commission, warns about sellers who insist on payment only by bank transfer, wire transfer, digital money called cryptocurrency, payment app or gift card. Such demands are a sign of a scam.
A low price alone does not settle whether an offer is legitimate; other checks still matter.